Abstract The purpose of this study was to determine metal ion levels in central visual system structures of the DBA/2J mouse model of glaucoma. We used inductively coupled plasma mass spectrometry (ICP-MS) to measure levels of iron (Fe), copper (Cu), zinc (Zn), magnesium (Mg), manganese (Mn), and calcium (Ca) in the retina and retinal projection of 5-month (pre-glaucomatous) and 10-month (glaucomatous) old DBA/2J mice and age-matched C57BL/6J controls. We used microbeam X-ray fluorescence (l-XRF) spectrometry to determine the spatial distribution of Fe, Zn, and Cu in the superior colliculus (SC), which is the major retinal target in rodents and one of the earliest sites of pathology in the DBA/2J mouse. Our ICP-MS experiments showed that glaucomatous DBA/2J had lower retinal Fe concentrations than pre-glaucomatous DBA/2J and age-matched C57BL/ 6J mice. Pre-glaucomatous DBA/2J retina had greater Mg, Ca, and Zn concentrations than glaucomatous DBA/2J and greater Mg and Ca than age-matched controls. Retinal Mn levels were significantly deficient in glaucomatous DBA/2J mice compared to agedmatched C57BL/6J and pre-glaucomatous DBA/2J mice. Regardless of age, the SC of C57BL/6J mice contained greater Fe, Mg, Mn, and Zn concentrations than the SC of DBA/2J mice. Greater Fe concentrations were measured by l-XRF in both the superficial and deep SC of C57BL/6J mice than in DBA/2J mice.
For the first time, we show direct measurement of metal concentrations in central visual system structures affected in glaucoma and present evidence for strain-related differences in metal content that may be specific to glaucomatous pathology.
Keywords Superior colliculus Á Retina Á ICP-MS Á Neurodegeneration Á Glaucoma Glaucoma is the leading cause of irreversible blindness worldwide, affecting an estimated 80 million people by 2020 (Quigley and Broman 2006) . The development of neuroprotective therapies for glaucoma has recently emerged as an essential strategy for preventing and treating this disabling disease (McKinnon et al. 2008) . Despite greatly increased interest in this line of research, effective interventions remain elusive (Osborne 2009; Danesh-Meyer 2011) , possibly because little is known about the causes, mechanisms, and progression of neurodegeneration in glaucoma. Insight into the underlying machinery behind glaucomatous neurodegeneration can come from research on other age-related neurodegenerative conditions, with which glaucoma shares similarities in epidemiology and proposed mechanisms (McKinnon 2003; Crish et al. 2010; Crish and Calkins 2011) .
Trace metals are essential for normal cellular function. This is especially evident in the central nervous system; among other functions, metal ions play a large role at the synapse. Metal ions such as zinc (Zn), iron (Fe), manganese (Mn), and copper (Cu) are critical cofactors needed for neurotransmitter synthesis; calcium (Ca) is essential for neurotransmitter release and plasticity; and Zn and magnesium (Mg) modulate synaptic activity (Sourkes 1972; Paoletti et al. 2009; Corona et al. 2011; Südhof 2012) . Given the importance of these molecules, concentrations in the nervous system are tightly regulated. One area of increasing interest as both a causative factor and target of intervention in neurodegenerative diseases is metal ion dyshomeostasis. Abnormal levels (both increases and decreases) of Cu, Zn, and Fe ions have been implicated in the pathogenesis and progression of a number of central nervous system neurodegenerative disorders, including Alzheimer's disease (DeToma et al. 2012; Pithadia and Lim 2012; Kepp 2012; Savelieff et al. 2013 ), Parkinson's disease (Dexter et al. 1992; Bisaglia et al. 2009 ), and Huntington's disease (Dexter et al. 1992) . Metals ions are important activators or cofactors for many transporters, transcription factors, and enzymes. Therefore, tight regulation of metal ion levels is essential for normal cellular function. Even minor alterations in these metal ions can have dramatic effects on cell physiology and survival (Sigel et al. 2006) .
Given the overlap in pathological progression between glaucoma and other neurodegenerative diseases, it is surprising that only a handful of studies have investigated metal ions in glaucoma. In this sparse body of work, there is indirect evidence of metal ion involvement in glaucoma; upregulation of metal-regulating genes and proteins have been shown in human glaucomatous retinas (Farkas et al. 2004; Stasi et al. 2007) , and in monkey (Farkas et al. 2004; Stasi et al. 2007; Miyahara et al. 2003 ) and mouse models of glaucoma (Stasi et al. 2007; Miyahara et al. 2003; Steele et al. 2006) . The roles of the metals themselves in glaucomatous neurodegeneration is unknown; however, Cu and Zn ions have been evaluated in terms of their relationship with intraocular pressure (IOP) modulation (Akyol et al. 1990; Iqbal et al. 2002) , the major modifiable risk factor in glaucoma. This relationship, however, was not investigated in the context of the neural changes that cause vision loss. A promising finding that was recently reported is that Mg supplementation was shown to improve visual field deficits in glaucoma (Aydin et al. 2010 )-implying metal ion levels as an attractive target for intervention.
Using inductively coupled plasma mass spectrometry (ICP-MS), we directly examined the levels of six metals commonly implicated in age-related neurodegeneration: Fe, Cu, Zn, Mg, Mn, and Ca) in the retina and retinal projection of the DBA/2J mouse model of glaucoma. Furthermore, we used microbeam X-ray fluorescence (l-XRF) spectrometry to determine the spatial distribution of Fe, Cu, and Zn in the superior colliculus (SC), the major retinal target in rodents and one of the earliest sites of pathology in the DBA/2J mouse (Crish et al. 2010 ).
Materials and methods

Animals
DBA/2J and C57BL/6J mice were obtained from breeding colonies at the Northeast Ohio Medical University's (NEOMED) Comparative Medicine Unit. Animals were originally obtained from Jackson Laboratories (Bar Harbor, ME). For ICP-MS, three animals from each strain were examined at two different: ages a) 5-months, an age that most DBA/ 2J mice would be considered ''pre-glaucomatous'' and b) 10-months, an age where we have found significant functional deficits but not large-scale neurodegeneration. For l-XRF, two animals from each strain at 5 and 12 months of age were examined. All mice were housed in the same room under the same environmental and husbandry conditions. All experiments involving animals adhered to the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the NEOMED Institutional Animal Care and Use Committee.
Tissue preparation
For ICP-MS, animals were anesthetized with 4 % isoflurane prior to cervical dislocation and decapitation. Retinas, optic nerves, SC, and cerebellum were rapidly dissected using Teflon-coated instruments and frozen on dry ice. Cerebellum was collected as a control structure as it is unaffected in glaucoma. For l-XRF, animals were anesthetized with ketamine/xylazine as described above and were transcardially perfused with 0.9 % NaCl followed by 4 % paraformaldehyde in 0.9 % NaCl. Brains were removed and cryoprotected overnight in 20 % sucrose/0.9 % NaCl and a microtome was used to collect uniform 50 lm coronal sections through the midbrain containing SC.
Determination of metal concentrations ICP-MS was performed at the Life Sciences Institute at the University of Michigan. Samples were treated with concentrated nitric acid for 2 h at 70°C followed by dilution with the equal volume of water. Metals were determined using a Thermo Scientific Element2
Inductively Coupled Plasma-High Resolution Mass Spectrometer and referenced either to the weight of the sample or the protein concentration as determined by a BCA assay. Values are reported in lmol (lM) of metal/mg total wet weight or protein.
l-XRF
Synchrotron microbeam X-ray fluorescence (l-XRF) spectrometry was performed as described previously (Miller et al. 2006; Leskovjan et al. 2009 Leskovjan et al. , 2011 . l-XRF measurements were conducted at the Biophysics Collaborative Access Team (BioCAT) beam at the Advanced Photon Source (APS) at Argonne National Laboratory (Argonne, IL). Tissues from 16 colliculi were obtained (2 animals per age group from 5 and 12 month C57BL/6J and DBA2/J mice). Each colliculus was treated as an independent sample. Tissues were placed in a high density polyethylene sample holder between two sheets of Ultralene (SPEX SamplePrep, Metuchen, NJ). Analyses of metal contents and distributions were conducted in non-overlapping regions of interest (ROI) of various sizes within the retinal ganglion cell layers in the retina and the SC region of the brain using l-XRF at the Biophysics Collaborative Access Team (BioCAT) beamline 18 at the Advanced Photon Source (APS) at Argonne National Laboratory (Argonne, IL, USA). The synchrotron X-ray beam was tuned to 10 keV using a Si(111) double crystal monochromator. In the brain tissue, the SC is restricted to the upper 300 lm of the tissue that remains upon removal of the cortex; an ROI sufficiently large to encompass this area was scanned. The incident beam was focused to 10 9 10 or 20 lm 9 20 lm at the sample using KirkpatrickBaez mirrors. Spectra were collected with a dwell time of 250 ms/pixel and 10 or 20 lm step size. Variations due to beam flux were normalized based on changes in I 0 .
Data were processed in MatLab using an adaptation of a program which produced a map of the distribution of metals. Metal concentrations were estimated by comparison with the intensity from thin metal foils (Fe, 0.1 lm, Cu, 0.1 lm, and Zn, 0.08 lm) measured under identical conditions. The approximate molar concentration was determined by accounting for the thickness of the tissue, assuming a density of 1 g/cm
Data analysis
For the ICP-MS study, data were analyzed using 2 9 2 factorial analyses of variance (ANOVA) with strain (C57BL/6J vs. DBA/2J) and age (5 vs. 10 months) serving as between subjects' factors and metal concentrations serving as the dependent variables. Separate analyses were conducted for each metal in each of four targeted brain regions (i.e., retina, optic nerve, SC and cerebellum). Post-hoc comparisons using Tukey's Honestly Significant Differences (HSD) tests were used to define relationships revealed by significant main effects and/or strain by age interactions.
For the l-XRF study, our allotted beam time at the APS only allowed us to image sections from two 5 and two 10 month C57BL/6J SC and one 5 and two 12 month DBA/2J SC. Given the small sample size, we pooled data across ages from each strain. Our main comparisons were the superficial (retinorecipient) SC and deep SC between the strains. Data were analyzed with either one-way ANOVAs or nonparametric Kruskal-Wallis tests (in cases where datasets did not have normal distributions) to assess differences between DBA/2J mice and C57BL/6J controls in three different metal concentrations (Fe, Zn, and Cu) in either superficial or deep SC. Fig. 1 Mean concentration (lM) of metals in the retina by mouse strain (DBA/2J; C57BL/6J) and age-group (5 and 10 months). Iron: Glaucomatous DBA/2J (10-month old) retina showed lower iron concentrations than 10-month old C57BL/6J control mice retina (p \ 0.01). Additionally, 10-month old DBA/2J retina had lower iron content than pre-glaucomatous (5-month old) DBA/2J retina (p \ 0.01). There were no differences in retinal iron content between strains at 5-months (p = ns). Manganese: Retinal manganese levels were significantly deficient in 10-month old DBA/2J mice compared to agedmatched C57BL/6J mice (p \ 0.01) and 5-month old DBA/2J mice (p \ 0.05). Retinal manganese levels did not differ between strains at 5-months (p = ns). Magnesium & calcium: 5-month old DBA/2J retina had greater magnesium and calcium concentrations than age-matched C57BL/6J mice (p \ 0.05 for both Mg & Ca). 5-month old DBA/2J also had significantly greater retinal magnesium and calcium than 10-month old DBA/ 2J mice (p \ 0.01 for both Mg & Ca). By 10-months of age, both DBA/2J and C57BL/6J retina did not differ in magnesium or calcium content. Zinc: 5-month old DBA/2J retina mice showed over two-fold greater zinc concentrations than 10-month old DBA/2J retina (p \ 0.01). There were no other statistically significant differences between groups, but the data show a trend towards higher zinc concentrations in 5-month DBA/2J retina compared to all C57BL/6J retina. Statistically significant differences between groups are indicated by asterisks. n = 6/ group
Results
ICP-MS
Retina
Main effects for age were shown in Fe (F 1,23 = 6.40), Mg (F 1,23 = 7.61), Ca (F 1,23 = 11.67) and Zn (F 1,23 = 10.43) concentrations (all p \ 0.05 for all); however, these results were qualified by significant strain by age interactions in metal concentration for Fe (F 1,23 = 14.45, p \ 0.01), Mg (F 1,23 = 4.92, p \ 0.05), Ca (F 1,23 = 8.08, p = 0.01), and Zn (F 1,23 = 5.86, p \ 0.05). Additionally, a significant strain by age interaction was shown for retinal Mn level (F 1,23 = 6.32, p \ 0.05). Analyses of the simple main effects for these interactions are described as follows and are illustrated in Fig. 1 . Mean metal concentrations in retina for each group analyzed are provided in Table 1 .
Iron Tukey post hoc analyses revealed that glaucomatous DBA/2J (10-month old) retina had lower Fe concentrations than retina from age-matched C57BL/6J control mice (p \ 0.01). Additionally, 10-month old DBA/2J retina had lower Fe than pre-glaucomatous (5-month old) DBA/2J retina (p \ 0.01). Retina from 5-month old DBA/2J and age-matched C57BL/6J mice did not differ in Fe content (p = ns).
Manganese Retinal Mn levels were significantly deficient in 10-month old DBA/2J mice compared to aged-matched C57BL/6J (p \ 0.01) and 5-month old DBA/2Js (p \ 0.05). Retinal Mn levels did not differ between strains at the 5-month age point (p = ns).
Magnesium Pre-glaucomatous (5-month old) DBA/ 2J retina had greater Mg concentrations than their agematched controls (p \ 0.05). The 5-month old DBA/ 2J also had significantly greater retinal Mg than 10-month old DBA/2J mice (p \ 0.01). At 10-months of age, neither DBA/2J nor C57BL/6J retina differed in Mg content (p = ns).
Calcium The same pattern of results shown for Mg concentration were obtained for retinal Ca levels. The 5-month DBA/2J retina had greater Ca concentrations than their age-matched C57BL/6J controls (p = 0.01) and 10-month DBA/2J mice samples (p \ 0.01). No differences in Ca content were seen between strains at 10-months (p = ns).
Zinc The retina of pre-glaucomatous DBA/2J mice showed over two-fold greater Zn concentrations than 10-month old DBA/2J retina (p \ 0.01). There were no other statistically significant differences between groups, but the data show a trend towards higher Zn concentrations in 5-month DBA/2J retina compared to C57BL/6J (5-month and 10-month) retina as well (see Fig. 1 ).
Copper No differences in retinal Cu levels were shown between any of the groups of the study.
Optic nerve A significant main effect for strain was shown in optic nerve Fe concentration, F 1,23 = 6.277, p \ 0.05. Independent of age, DBA/2J mice exhibited lower concentrations of Fe (mean uM ± SEM = 123.50 ± 28.77) in the optic nerve compared to C57BL/6J controls (mean uM ± SE = 217.87 ± 21.88; Tukey Table 3 ). While there are no significant age effects, it is notable that the data show trends towards lower metal concentrations in the glaucomatous (10-month old) DBA/2J SC in contrast to 5-month old DBA/2J and C57BL/6J controls. No differences in Ca and Cu levels were shown between any of the groups. The breakdown for individual group means for each metal concentration are shown in Table 4 . Cerebellum A significant main effect for strain was shown for cerebellar Zn content, F 1,23 = 5.46, p \ 0.05. DBA/ 2J mice (mean uM ± SEM = 120.04 ± 4.59) had overall greater Zn concentrations in their cerebellum compared to C57BL/6J control mice (mean uM ± SEM = 106.6 ± 3.08; p \ 0.05). Cerebellar Fe content was shown to differ significantly as a function of animal age, F 1,23 = 11.46, p \ 0.01. Older animals (10-months; mean uM ± SEM = 280.6 ± 13.97) showed more accumulation of iron in their cerebellum than their younger counterparts (5-months; mean uM ± SEM = 223.4 ± 9.23) regardless of strain.
No differences in cerebellar Mg, Mn, Ca, or Cu were indicated between groups. Individual group means for metal concentration are shown in Table 5 .
l-XRF
Due to small sample size, data were pooled across ages for each of the strains; therefore, no age-related effects were assessed. Initial qualitative analyses showed that the distribution of Fe was relatively uniform throughout the SC, while Cu and Zn were identifiable in more discrete regions of this tissue. The quantitative results of the l-XRF study showed that Fe concentrations were significantly greater in C57BL/6J animals than DBA/2J mice in both the superficial (F 1,7 = 44.58, p \ 0.001) and deep SC (F 1,7 = 19.92, p \ 0.01). Additionally, control animals had greater Zn concentrations in superficial SC than DBA/2J mice (F 1,7 = 7.93, p \ 0.05). There was no difference in Zn in the deep SC. Consistent with the ICP-MS studies, no differences in Cu concentration were shown between strains in either area of the SC. Results of this experiment are shown in Fig. 2 .
Discussion
Disruptions of metal levels can result in severe dysfunction and degeneration in the nervous system (Sigel et al. 2006) . Abnormal metal metabolism has been postulated to play a role in the progression of pathology in glaucoma, yet few studies have quantified metal content in the tissues affected in this disease. Here, we examined metal concentration in the retinas and retinal projections of the DBA/2J mouse model of glaucoma and found significant decreases in a variety of metals. The cerebellum was chosen as a control structure because it appears to be unrelated to the visual and auditory defects characteristic of the DBA/2J. It was easily accessed in our dissection and its globular structure allowed quick and reproducible selection of tissue. In assessing metal concentration, the cerebellum gave consistent results with low variability among experimental groups. Four of the metals tested did not show any difference between age or strain in this structure. Fe increased in similar magnitude with age in both strains, and only Zn showed a minor (*12 %) increase in DBA/2J mice compared to C57BL/6J mice. Therefore, any differences in metal concentration shown in the central visual system structures likely are related to pathology associated with the visual system and not just a reflection of global changes in metal content of the brain.
Our retina results were striking as we found increased metal levels in young DBA/2J mice and reduced levels of metals in our aged DBA/2J animals. One explanation is that metal level elevations seen in other neurodegenerative diseases during overt degeneration (Sigel et al. 2006 ) may actually occur early in the DBA/2J retina. There is evidence that ceruloplasmin, a metal handling protein is elevated in 8 month DBA/2J mice (Steele et al. 2006 ). This raises the possibility that these elevations drive pathological progression through mechanisms reported in other disorders, such as increased oxidative stress and facilitation of protein aggregation (Gaeta and Hider 2005) . At 5 months, we expect little if any RGC loss in DBA/2J mice, yet significant dendritic pruning and synapse loss has been reported in other studies (Jakobs et al. 2005; Stevens et al. 2007) . Given the importance of metals at synapses (Frederickson 1989; Tamano and Takeda 2011) , it is possible that reductions in metal concentrations in 10-month old DBA/2J mouse visual structures are due to synaptic stripping and lack of resulting neuronal signaling. Conversely, our colliculus data revealed decreased metal levels in the SC of DBA/2J mice regardless of age-although with some metals, there was evidence in C57BL/6J control mice (n = 4) compared to DBA/2J mice (n = 3) in both the superficial and deep SC. C57BL/6J mice had greater Zn content in superficial SC than DBA/2J mice. There was no difference in Zn in the deep SC. No differences in Cu concentration were shown between strains in either area of the SC. Asterisks indicate statistically significant results. Due to small sample size, data were pooled across 5 and 12 month ages in both strains of trend towards lower concentrations in older animals. Early disruption of metal levels of the SC is consistent with our emerging understanding of early changes in glaucoma. The SC is the major target of the retina in rodents and an early site of the manifestation of pathology (Crish et al. 2010) . Given that it is a location rich in retinal ganglion cell (RGC) synapses, it is not surprising that metal loss was observed. While RGC dendrites and synapses in the retina are also affected early in disease progression, we did not see significant metal decreases in the retina until older ages. There are few possibilities explaining this disparity. Due to the organization of the retina, RGC synapses from bipolar and other retinal cells that are affected disproportionately in glaucoma are relatively fewer in number than other synapses in this tissue. Contrasting with that, a larger percentage of the synapses in the superficial SC are synapses from RGCs (Valverde 1973) . Additionally, the retinocollicular synapses are classic glutamatergic presynaptic boutons and the synaptic compartment affected in the glaucomatous retina is postsynaptic. Much of the synaptic metals are stored presynaptically (Sourkes 1972; Paoletti et al. 2009; Corona et al. 2011) and it is unclear is how the presynaptic portion of these synapses are affected in early glaucoma. We might expect more changes in metal concentrations at presynaptic regions of RGCs (i.e., regions located in the brain).
Data obtained from the l-XRF experiments supports results from our ICP-MS data that show reductions in iron content in the DBA/2J mouse SC. Our l-XRF data also showed reduced zinc content in the superficial (retinorecipient) layers of the DBA/2J SC. While we were not able to test age-related differences due to small sample size, the l-XRF technique shows promise for allowing us to evaluate sectorial changes in metal concentration in different portions of the SC.
Sectorial changes in structure and function are pathological hallmarks of glaucoma (Soto et al. 2008; Crish et al. 2010 ). Assessing differences in metal concentration between adjacent tissue sections of the same structure based on pathology would be a powerful technique for determining subtle but important differences in metal concentration. Our data, while preliminary, provide proof of concept that this technique may have a great potential for yielding meaningful results going forward with larger sample sizes.
The Phenome Database at Jackson Laboratories (Yuan and Korstanje 2014) reported blood levels of Ca in DBA/2J and C57BL/6J mice vary little (1-7 %) between the two strains at 6, 12, or 18 months of age (see Table 6 ). In mice that were similar to the age ranges we tested in the current study (6 and 12 months), blood levels of Fe presented were higher in DBA/2Js than C57BL/6J mice (Yuan and Korstanje 2014) , opposite of our findings for Fe content in the SC and in the retina of 10-month old DBA/2J mice (recall Fig. 1 ). By 18 months of age, older than we tested in the current study, blood levels of Fe between the strains were equivalent. Blood levels of Mg were similar between the two strains at 6 and 12 months of age (Table 6 )-this was not the case with Mg content in the retina which was lower in C57BL/6J and 10-month old DBA/2J mice compared to 5-month old DBA/2J mice. Additionally, our SC data showed higher Mg concentrations overall in C57BL/6J mice. These differences in the reported blood metal concentration data and our visual system structure data suggest that any differences we are seeing between strains in the current study are unlikely to be nonspecific, but are associated with specific degeneration and dysfunction of the visual system. This assertion is also corroborated by our cerebellar control data that do not reflect strain-related differences in metal concentration. We report here, for the first time, the direct measurement of metal concentrations in central visual system structures affected in glaucoma using ICP-MS and l-XRF technology. While in their infancy, these explorations into the significance of metal concentrations in glaucoma, suggest this may be a fertile avenue for investigating ways to therapeutically manipulate metal levels in this disorder, as has been suggested in other neurodegenerative disorders (Corona et al. 2011) .
